Leidos Holdings (LDOS) Aktievy
Leidos Holdings, Inc, tillsammans med sina dotterbolag, tillhandahåller tjänster och lösningar för statliga och kommersiella kunder i USA och internationellt. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 6/6 |
| Framtida tillväxt | 2/6 |
| Tidigare resultat | 3/6 |
| Finansiell hälsa | 3/6 |
| Utdelningar | 5/6 |
Belöningar
Riskanalys
LDOS Community Fair Values
Create NarrativeSee what 87 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Leidos Holdings, Inc. Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | US$104.32 |
| 52 veckors högsta | US$205.77 |
| 52 veckors lägsta | US$101.09 |
| Beta | 0.51 |
| 1 månads förändring | -17.21% |
| 3 månaders förändring | -33.80% |
| 1 års förändring | -32.24% |
| 3 års förändring | 20.36% |
| 5 års förändring | 3.19% |
| Förändring sedan börsintroduktionen | 43.45% |
Senaste nyheter och uppdateringar
Ny berättelse • Jun 17
Leidos Stock Will Ride NorthStar 2030 And AI Missions For Long-Term Upside
Catalysts About Leidos Holdings Leidos Holdings is a technology-focused defense, intelligence, health, and infrastructure company that delivers mission-critical systems, services, and products to government and commercial customers. What are the underlying business or industry changes driving this perspective?Analysartikel • Jun 17
Leidos Holdings (LDOS) Stock Could Be 38% Undervalued After Downgrade And DHA Contract Pressure
Leidos Holdings (LDOS) is back in focus after a Jefferies downgrade and fresh concerns about profit margins and U.S. defense budgets, along with additional pressure from changes to a key Defense Health Agency contract. See our latest analysis for Leidos Holdings. Leidos Holdings has come under pressure, with the share price down 31.9% over the past 90 days and the 1 year total shareholder return declining 23.2%, although the 3 year total shareholder return of 38.0% still reflects earlier...
Uppdatering av berättelse • Jun 10
LDOS: Hypersonic Weapons Production Contract Will Drive Future Re Rating Potential
Analysts have trimmed their fair value estimate for Leidos Holdings by about $3 to $183.27, reflecting lower organic growth and profit margin assumptions after several firms cut price targets, including a Jefferies downgrade to Hold and reduced long term EPS expectations. This was partly offset by fresh positive coverage such as an Outperform initiation at BNP Paribas with a $165 target.Recent updates
Ny berättelse • Jun 17
Leidos Stock Will Ride NorthStar 2030 And AI Missions For Long-Term Upside
Catalysts About Leidos Holdings Leidos Holdings is a technology-focused defense, intelligence, health, and infrastructure company that delivers mission-critical systems, services, and products to government and commercial customers. What are the underlying business or industry changes driving this perspective?Analysartikel • Jun 17
Leidos Holdings (LDOS) Stock Could Be 38% Undervalued After Downgrade And DHA Contract Pressure
Leidos Holdings (LDOS) is back in focus after a Jefferies downgrade and fresh concerns about profit margins and U.S. defense budgets, along with additional pressure from changes to a key Defense Health Agency contract. See our latest analysis for Leidos Holdings. Leidos Holdings has come under pressure, with the share price down 31.9% over the past 90 days and the 1 year total shareholder return declining 23.2%, although the 3 year total shareholder return of 38.0% still reflects earlier...Uppdatering av berättelse • Jun 10
LDOS: Hypersonic Weapons Production Contract Will Drive Future Re Rating Potential
Analysts have trimmed their fair value estimate for Leidos Holdings by about $3 to $183.27, reflecting lower organic growth and profit margin assumptions after several firms cut price targets, including a Jefferies downgrade to Hold and reduced long term EPS expectations. This was partly offset by fresh positive coverage such as an Outperform initiation at BNP Paribas with a $165 target.Uppdatering av berättelse • May 27
LDOS: Federal IT Wins And Hypersonic Programs Will Support Re Rating
Leidos Holdings' analyst price target has been revised lower by roughly $13 to about $186, as analysts update their models for a higher discount rate, a lower future P/E, and refreshed views from recent target cuts and a neutral initiation alongside one target increase. Analyst Commentary Recent Street research on Leidos Holdings has centered on recalibrated price targets, with several reductions and one increase, along with a fresh neutral initiation.Seeking Alpha • May 26
Leidos: The Market Is Mispricing This Defense Giant, Again
Summary Leidos (LDOS) is rated Strong Buy as the market underappreciates its alignment with federal priorities and robust operational performance. LDOS raised full-year guidance across all metrics, reporting Q1 revenue and EPS beats, and a record $48.4B backlog, yet trades at 10.5x forward earnings. ENTRUST acquisition expands LDOS’s cybersecurity capabilities, is immediately accretive, and positions the company for multi-year digital modernization tailwinds. Current valuation is compelling given mid-teens EBITDA margins, disciplined capital allocation, and strategic contract wins in missile defense and hypersonic weapons. Read the full article on Seeking AlphaUppdatering av berättelse • May 02
LDOS: Defense Tech Contracts And AI Alliance Will Offset 2026 VBA Drag
The updated analyst price target for Leidos Holdings has been trimmed by about $5 to roughly $199 per share. Analysts factored in recent target cuts around mixed Q4 results, modestly lower revenue growth assumptions, a slightly higher discount rate, and a somewhat lower future P/E multiple, even as profit margin expectations edge up.Uppdatering av berättelse • Apr 17
LDOS: Defense Tech And AI Partnership Will Offset 2026 VBA Headwinds
Leidos Holdings' updated analyst price target has moved lower by about $5 per share to reflect a slightly higher discount rate, a reduced future P/E assumption, and tempered margin expectations, as analysts factor in mixed Q4 results, recent target cuts from several firms, and ongoing headwinds in Veterans Benefits Administration work, even as growth initiatives continue. Analyst Commentary Recent research updates on Leidos point to a more cautious valuation framework, even as some analysts still see upside tied to growth investments and capital allocation changes.Uppdatering av berättelse • Apr 03
LDOS: Defense Tech And AI Contracts Will Offset 2026 VBA Slowdown
Analysts have trimmed the average price target for Leidos Holdings to $209 from about $212, reflecting slightly higher discount rate assumptions, modestly adjusted growth and margin expectations, and mixed reactions to recent Q4 results and contract headwinds. Analyst Commentary Recent research paints a mixed picture around Leidos Holdings, with both optimistic and cautious views emerging after the latest Q4 report, updated guidance, and evolving contract exposure.Uppdatering av berättelse • Mar 19
LDOS: Defense Tech And AI Expansion Will Offset 2026 VBA Contract Slowdown
Analysts have trimmed the blended price target on Leidos Holdings by about $1.50 to roughly $212.50, reflecting slightly softer long term growth and margin assumptions after mixed Q4 results and evolving views on the VBA headwind and defense tech opportunities. Analyst Commentary Street research on Leidos Holdings has shifted toward a more balanced view, with price targets generally nudged lower and ratings clustered around Buy, Outperform, Hold, and Neutral.Uppdatering av berättelse • Mar 05
LDOS: Defense Tech And AI Shift Will Offset 2026 VBA Headwinds
Analysts have reduced their blended price target for Leidos Holdings by about $4 to roughly $214, reflecting recent Q4 updates, mixed views on growth in 2026, and ongoing debate around the impact of slower Veterans Benefits Administration work versus opportunities in defense tech and other growth segments. Analyst Commentary Street research on Leidos presents a split view, with several firms trimming price targets after Q4 while still highlighting long term growth opportunities in defense technology and other higher growth areas.Uppdatering av berättelse • Feb 18
LDOS: Defense Tech And AI Shift Will Support Premium Multiple
The updated fair value estimate for Leidos Holdings edges down to about $218 per share from roughly $219, as analysts adjust price targets lower, citing mixed Q4 results, a slowdown in Veterans Benefits Administration activity, and tempered views on future valuation and guidance, even as the company increases its focus on higher growth markets. Analyst Commentary Recent Street research on Leidos points to a split view, with some analysts focusing on long term growth opportunities and others stressing execution risks and valuation constraints following the latest Q4 report and guidance.Uppdatering av berättelse • Feb 04
LDOS: Entrust Acquisition And AI Partnerships Will Support Premium Multiple
Analysts nudged their blended price target on Leidos Holdings slightly higher to about US$219.31, reflecting a modestly higher assumed future P/E multiple while balancing recent target moves tied to enthusiasm around the Entrust acquisition and caution over potential 2026 contract headwinds. Analyst Commentary Recent research on Leidos highlights a split view, with some analysts leaning into the potential of the Entrust acquisition and others more focused on contract concentration and 2026 risk.Uppdatering av berättelse • Jan 21
LDOS: Health And Civil Strength And VA Contract Risk Will Shape Premium Multiple
Narrative Update: Leidos Holdings Analysts have trimmed their blended price target on Leidos Holdings by about $1 per share to $219, reflecting slightly more conservative assumptions on revenue growth, margins, and future P/E, after balancing recent target increases from firms citing strong execution and portfolio positioning with concerns around a key high margin contract and the timing of proving its sustainability. Analyst Commentary Recent research on Leidos highlights a mix of optimism around the core business and caution around a key contract that could affect medium term growth and valuation multiples.Uppdatering av berättelse • Jan 07
LDOS: Health And Civil Strength And Pipeline Visibility Will Support Premium Multiple
Analysts have nudged their fair value estimate for Leidos Holdings higher to about $219.85 from roughly $218.08, citing stronger recent earnings, solid Health & Civil margins, a 1.3x book to bill, a US$69b near term pipeline, and a view that the company merits a premium P/E multiple within government services. Analyst Commentary Bullish Takeaways Bullish analysts see the recent earnings beat as support for a higher fair value, pointing to execution in Health & Civil margins as a key driver of profitability.Uppdatering av berättelse • Dec 16
LDOS: Strong Health And Civil Margins Will Support Future Premium Multiple
Analysts have raised their price target on Leidos Holdings to approximately $218.08 per share from about $218.08. This reflects slightly stronger expectations for revenue growth and sustained margins, supported by robust book to bill trends, a sizable near term pipeline, and upside earnings performance with higher profitability guidance into 2025.Uppdatering av berättelse • Dec 02
LDOS: Strong Health And Civil Margins Will Support Continued Margin Upside
Leidos Holdings saw its average analyst price target rise from $210 to $230 as analysts highlighted robust Health & Civil margins, a strong contract pipeline, and increased profitability guidance following recent earnings results. Analyst Commentary Recent analyst reports have highlighted several factors influencing sentiment around Leidos Holdings following the latest earnings results and guidance updates.Uppdatering av berättelse • Nov 18
LDOS: Near-Term Contract Pipeline Will Drive Continued Margin Upside
Leidos Holdings' analyst price target has increased from $201.83 to $218.08 per share, as analysts cite strong margins in Health and Civil segments, a robust $69 billion pipeline, and raised profitability guidance as driving factors for the upward revision. Analyst Commentary Recent analyst reports have highlighted several factors that shape both the bullish and cautious outlooks for Leidos Holdings following its stronger-than-expected earnings performance and revised guidance.Analysartikel • Nov 06
Leidos Holdings (NYSE:LDOS) Is Increasing Its Dividend To $0.43
Leidos Holdings, Inc. ( NYSE:LDOS ) will increase its dividend from last year's comparable payment on the 31st of...Uppdatering av berättelse • Nov 02
LDOS: Federal Health And Security Spending Will Drive Steady Performance Ahead
Leidos Holdings saw its analyst price target rise from approximately $198.50 to $201.83. Analysts cited the company’s ongoing momentum in health services, robust margins, and its positioning to benefit from expanding federal funding priorities.Uppdatering av berättelse • Oct 18
Government Funding And Digital Transformation Will Create Future Value
The average analyst price target for Leidos Holdings was raised by approximately $4 to $198.50. Analysts highlighted improving healthcare margins, stronger execution in health and defense services, and the company's positioning to benefit from recent government funding priorities.Uppdatering av berättelse • Oct 04
Government Funding And Digital Transformation Will Create Future Value
The analyst price target for Leidos Holdings has been increased by approximately $2 to $194.71, as analysts cite ongoing strength in healthcare margins, opportunities in defense solutions, and improved business execution as key factors supporting the higher valuation. Analyst Commentary Recent Street research updates reflect a generally positive outlook on Leidos Holdings, with multiple analysts raising their price targets and upgrading the stock in response to improved business execution and strong performance in key sectors.Uppdatering av berättelse • Sep 19
Government Funding And Digital Transformation Will Create Future Value
Upward analyst revisions for Leidos Holdings reflect confidence in its strategic investments in health and border security, strong healthcare margins, and effective leadership, resulting in a modest price target increase from $190.15 to $192.66. Analyst Commentary Bullish analysts highlight Leidos' strategic investments in veteran health, border security, and autonomous maritime, positioning the company to benefit from new government funding priorities.Analysartikel • Sep 06
Here's Why Leidos Holdings (NYSE:LDOS) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Uppdatering av berättelse • Sep 04
Government Funding And Digital Transformation Will Create Future Value
Analysts maintain a positive outlook on Leidos Holdings due to strong execution in Health Services, favorable positioning for government funding priorities, increased management confidence, and a strategic pivot toward higher-margin growth sectors, resulting in an unchanged $186.69 price target. Analyst Commentary Continued strength and solid execution within Leidos' Health Services business, contributing to improved outlook and confidence.Seeking Alpha • Apr 15
Leidos: A Defense Company To Consider
Summary Leidos Holdings, Inc. operates in defense, IT security, data analytics, and healthcare, recently realigning into four segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Leidos has shown strong performance, boasting a 450% total return over the past decade, exceeding returns of the overall market. The company has been growing its dividend for a few years, but I think they could offer investors higher increases. Read the full article on Seeking AlphaSeeking Alpha • Feb 02
Leidos: Fears Are Overblown, Take Advantage Of Market Uncertainty
Summary Leidos' shares have dropped significantly due to policy uncertainties, presenting a buying opportunity given its strong backlog and free cash flow generation. The company's Q3 '24 results showed robust growth with a 44% EPS increase and a $40.6 billion backlog, signaling future revenue stability. Despite political risks, Leidos' valuation is attractive at 10.3x EV/EBITDA, with strong dividend and share buyback potential. I rate Leidos a 'strong buy' due to its discounted valuation, solid financial position, and growth prospects in Health & Civil and National Security segments. Read the full article on Seeking AlphaSeeking Alpha • Nov 22
Leidos: Not Enough Margin Of Safety Despite Creating Value In A Low Growth Sector
Summary LDOS has consistently created shareholder value through a mix of organic growth and acquisitions. Despite improving operating and capital efficiencies, LDOS's returns have not shown an improving trend, and its valuation currently does not provide enough margin of safety. LDOS is financially sound with a good reinvestment rate and cash flow. But I recommend waiting for a 15% price drop before buying. Read the full article on Seeking AlphaAktieägarnas avkastning
| LDOS | US Professional Services | US Marknad | |
|---|---|---|---|
| 7D | -4.0% | -1.5% | -2.5% |
| 1Y | -32.2% | -24.7% | 20.1% |
Avkastning vs industri: LDOS presterade sämre än US Professional Services branschen som gav -24.7 % under det senaste året.
Avkastning vs Marknaden: LDOS presterade sämre än US marknaden som gav 20.1 % under det senaste året.
Prisvolatilitet
| LDOS volatility | |
|---|---|
| LDOS Average Weekly Movement | 4.2% |
| Professional Services Industry Average Movement | 7.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stabil aktiekurs: LDOS har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.
Volatilitet över tid: LDOS s veckovolatilitet ( 4% ) har varit stabil under det senaste året.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1969 | 50,000 | Tom Bell | www.leidos.com |
Leidos Holdings, Inc. tillhandahåller tillsammans med sina dotterbolag tjänster och lösningar för statliga och kommersiella kunder i USA och internationellt. Segmentet National Security & Digital tillhandahåller mjukvara för nationell säkerhet; tjänster genom att använda artificiell intelligens och maskininlärning för att samordna hav, mark, luft och rymd för att hjälpa krigare; offensiva, defensiva och fysiska cyberoperationslösningar; underrättelseanalys, operativt stöd, logistikoperationer, säkerhet, lingvistik, styrkeproduktion, biometri, kemiska, biologiska, radiologiska, nukleära och explosiva ämnen, energetik, utbildning och andra tjänster; samt Digital Modernization och transformationstjänster. Segmentet Health & Civil erbjuder flygtrafikledningssystem, mjukvara för hälsouppdrag, managed health services, förvaltning och drift av infrastruktur, logistisk verksamhet och IT-stöd samt stödtjänster för forskning och utveckling inom life science.
Leidos Holdings, Inc. Sammanfattning av grunderna
| LDOS grundläggande statistik | |
|---|---|
| Börsvärde | US$13.35b |
| Vinst(TTM) | US$1.41b |
| Intäkter(TTM) | US$17.33b |
9.3x
P/E-förhållande0.8x
P/S-förhållandeÄr LDOS övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| LDOS resultaträkning (TTM) | |
|---|---|
| Intäkter | US$17.33b |
| Kostnad för intäkter | US$14.23b |
| Bruttovinst | US$3.10b |
| Övriga kostnader | US$1.69b |
| Intäkter | US$1.41b |
Senast redovisade vinst
Apr 03, 2026
Nästa vinstdatum
n/a
| Vinst per aktie (EPS) | 11.23 |
| Bruttomarginal | 17.91% |
| Nettovinstmarginal | 8.15% |
| Skuld/egenkapitalförhållande | 124.1% |
Hur har LDOS utvecklats på lång sikt?
Se historisk utveckling och jämförelseUtdelningar
1.6%
Aktuell utdelningsavkastning15%
UtbetalningskvotGer LDOS en tillförlitlig utdelning?
Se LDOS utdelningshistorik och jämförelsetal| Leidos Holdings datum för utdelning | |
|---|---|
| Ex utdelningsdag | Jun 15 2026 |
| Utbetalningsdag för utdelning | Jun 30 2026 |
| Dagar till Ex-utdelning | 10 days |
| Dagar till utdelningsdag | 5 days |
Ger LDOS en tillförlitlig utdelning?
Se LDOS utdelningshistorik och jämförelsetalFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/06/24 07:10 |
| Aktiekurs vid dagens slut | 2026/06/24 00:00 |
| Intäkter | 2026/04/03 |
| Årlig intjäning | 2026/01/02 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa denna rapport finns på vår Github-sida; vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Leidos Holdings, Inc. bevakas av 24 analytiker. 15 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| John Eade | Argus Research Company |
| Peter Arment | Baird |
| David Strauss | Barclays |